Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response.

Treatment of chronic hepatitis C virus (HCV) infection is evolving rapidly with the development of novel direct acting antivirals (DAAs), however viral clearance remains intimately linked to the hepatic innate immune system. Patients demonstrating a high baseline activation of interferon stimulated...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Scott A Read, Enoch S Tay, Mahsa Shahidi, Kate S O'Connor, David R Booth, Jacob George, Mark W Douglas
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Public Library of Science (PLoS) 2015-01-01
Edice:	PLoS ONE
On-line přístup:	https://doi.org/10.1371/journal.pone.0136227
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!